General Archive
-
News releases
LifeArc launches £100,000 awards – now closed
We have launched the LifeArc Translational Award for academic scientists to progress early stage drug discovery projects.
-
News releases
Juan Carlos Lopez to assist business development in North America
LifeArc has appointed Juan Carlos Lopez, founder of Haystack Science, to assist their business development activity in North America on…
-
News releases
Partnership with Metrion Biosciences to support LifeArc’s neuroscience small molecule drug discovery programme
Metrion to provide in-depth ion channel target class knowledge and assay support.
-
News releases
LifeArc becomes technology transfer partner to London School of Hygiene & Tropical Medicine
LifeArc has signed an agreement with the London School of Hygiene & Tropical Medicine to provide a range of technology…
-
News releases
LifeArc negotiates exclusive licence deal with Nemysis Limited for oral iron supplement technology
LifeArc has negotiated a licence for an oral iron supplement technology with Nemysis Limited (Nemysis). Iron oxo-hydroxide adipate tartrate (IHAT)…
-
News releases
LifeArc, Dstl and CDRD collaborate to identify antibacterial drug targets
LifeArc, The Centre for Drug Research and Development (CDRD), and the Defence Science and Technology Laboratory (Dstl) announced a collaboration…
-
News releases
LifeArc set to transform medical research landscape
Investing up to £500 million over the next five years to generate, fund and champion innovations in antimicrobials, neuroscience, personalised oncology…
-
News releases
MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer
Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated Idylla™ platform
-
News releases
Applying artificial intelligence in the search for new drugs
London, 11 April 2017 – BenevolentAI, a British artificial intelligence company, today announced that it has partnered with MRC Technology…
-
News releases
Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments
London, UK, 15 March 2017: The Dementia Consortium, a public-private partnership initiative bridging the gap between academic research and the…
-
News releases
MRC Technology licenses antibody to Newsummit Biopharma for development of Hepatitis C virus infection therapeutic
MRC Technology has licensed an antibody to Newsummit Biopharma for development of a novel therapeutic for treatment of Hepatitis C…
-
News releases
MRC Technology joins project UTILE to enable medical breakthroughs from European funded research
MRC Technology is committed to ensuring that promising medical research is protected and progressed to benefit patients. We are therefore…